CPHI & PMEC China 2026 unites suppliers and buyers across the entire pharmaceutical supply chain, positioning itself as a must-attend B2B event for companies seeking growth in one of the world’s most dynamic pharma markets.
The exhibition is expected to attract more than 110,000 attendees and feature over 3,600 local and international exhibitors, showcasing solutions across key sectors including pharmaceutical ingredients, biotechnology, natural products, contract services, excipients, and finished dosage. In addition, more than 100 content sessions will provide valuable insights into industry trends, innovation, and regulatory developments.
With its scale, influence, and strategic location, CPHI & PMEC China 2026 offers an essential platform for networking, sourcing, and business development within China’s rapidly evolving pharmaceutical ecosystem.
Stay informed about upcoming pharmaceutical, medical, and healthcare trade exhibitions across Asia by visiting our Andaman Medical website.
